Bharat Biotech concludes final analysis for COVAXIN, claims 77.8 pc efficacy from phase-3 clinical trials
Hyderabad, Jul 3 (UNI): Bharat Biotech, a global leader in vaccine development and innovation, announced on Saturday safety and efficacy ...
Hyderabad, Jul 3 (UNI): Bharat Biotech, a global leader in vaccine development and innovation, announced on Saturday safety and efficacy ...
New Delhi, Jun 30 (UNI): India has urged EU member countries to individually consider allowing persons who have taken ...
As international travel slowly opens up, countries are preparing standard protocols for issue of visa and travel documents. While United ...
Demonstrating its scientific commitment to data generation and data transparency, Bharat Biotech shared full data of all research studies of ...
In all 30 children, aged 12-18, were administered Covaxin at Mysuru Medical College and Research Institute (MMCRI) as part of ...
The Aam Aadmi Party government has responded to an observation of the Delhi High Court related to the shortage of ...
Five Medical institutions across the country have so far received institutional ethics committee approvals for Covaxin’s clinical trials on children ...
In a case of medical negligence reported from Siddharthnagar district of Uttar Pradesh, 20 villagers were administered a dose of ...
Hyderabad-based Bharath Biotech which has received permission to carry out pediatric trials of the Covid vaccine Covaxin, will commence its ...
The National Regulator of the country, the Drugs Controller General of India has granted permission to Bharat Biotech Ltd to ...
© Janam Multimedia Limited